Collectively, these data strongly suggest that activation of the Akt survival pathway plays a critical role in TRAIL resistance in ovarian and breast cancer cells and imply that inhibition of this survival pathway might overcome TRAIL resistance. This evidence concerns the gene AKT1 and breast carcinoma.